John Halpern
Corporate Officer/Principal chez Harvard Medical School
Profil
John Halpern was the founder of Entheogen Corp.
which was founded in 2010, where he held the title of Director & Chief Medical Officer.
Currently, he is an Assistant Professor at Harvard Medical School.
Previously, he worked as a Laboratory Director at McLean Hospital, Inc. Dr. Halpern's education includes an undergraduate degree from The University of Chicago and a doctorate from The State University of New York.
Postes actifs de John Halpern
| Sociétés | Poste | Début |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 10/02/2011 |
Anciens postes connus de John Halpern
| Sociétés | Poste | Fin |
|---|---|---|
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Corporate Officer/Principal | - |
Entheogen Corp.
 Entheogen Corp. BiotechnologyHealth Technology Entheogen Corp. manufactures biopharmaceutical products. Its 2-Bromo-LSD, known as BOL-148 provides treatment for cluster headache. The firm offers treatment for chronic headache like migraine and cluster headaches. The company was founded by John Halpern, Torsten Passie and Ari Mello in 2010 and is headquartered in Stow, MA. | Fondateur | - |
Formation de John Halpern
| The University of Chicago | Undergraduate Degree |
| The State University of New York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Entheogen Corp.
Entheogen Corp. BiotechnologyHealth Technology Entheogen Corp. manufactures biopharmaceutical products. Its 2-Bromo-LSD, known as BOL-148 provides treatment for cluster headache. The firm offers treatment for chronic headache like migraine and cluster headaches. The company was founded by John Halpern, Torsten Passie and Ari Mello in 2010 and is headquartered in Stow, MA. | Health Technology |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Health Services |
